Pfizer and SINOPHARM have entered into a new partnership to promote antifungal drug Diflucan in China. The collaboration also ...

Pfizer navigates a changing pharmaceutical landscape through pipeline expansion, innovation, and portfolio transformation as ...

Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.

Pfizer’s latest share move reflects renewed attention on its label expansion, research pipeline, dividend profile, and ...

For the second consecutive year, Pfizer is advertising at the Super Bowl. The pharma giant announced Friday morning that it is doubling down on its fight against cancer with a 60-second ad set to air ...

July 30 (Reuters) - Pfizer (PFE.N), opens new tab raised its annual profit forecast on Tuesday, helped by cancer treatments acquired through a $43 billion deal for Seagen and strong sales of its heart ...

Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again. Shares are up 9% today, trading near $57 in the Tuesday ...

The pharma company doesn’t have any obesity drugs on the market. Here’s how it plans to change that, and become an industry leader.

As its lead candidate advances into a late-stage trial for pulmonary arterial hypertension (PAH), Inhibikase Therapeutics has picked up a commercial leader with plenty of experience in the PAH space.